Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bile acid sequestrants are non-absorbable polymeric resins that bind to bile acids in the gastrointestinal tract, preventing their reabsorption and promoting their excretion. This leads to a reduction in LDL cholesterol levels. They are used in the treatment of hypercholesterolemia, bile acid malabsorption, and pruritus associated with cholestasis. Common examples include cholestyramine, colestipol, and colesevelam.
Binds bile acids in the gastrointestinal tract, preventing their reabsorption and promoting their excretion in feces. This forces the liver to convert more cholesterol into bile acids, lowering LDL cholesterol levels.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bile Acid Sequestrant.